VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GRDN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GRDNGuardian Pharmacy Services, Inc.
$46.94$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGRDNEarnings History

GRDN logoGuardian Pharmacy Services, Inc. (GRDN) Earnings History

Elite Compounder

8 years of earnings data (2018–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality

TTM Net Income
$75M
● Profitable
TTM EPS (Diluted)
$1.17
Per share, diluted
YoY EPS Growth
+144.1%
Excellent
Net Margin
3.4%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3Y+10.4%
5Y+18.8%
10YN/A
Operating Margin6.1%
Gross Margin19.5%
Return on Equity26.8%
Return on Assets13.4%
Record Annual Net Income$49MFY2025
Record Quarterly EPS$0.38Q4 2023
Consecutive Profitable Years1years
Q3 2026
Net Income$19M
EPS (Diluted)$0.29
YoY Growth+144.1%Excellent
QoQ Growth-14.6%Declining

Loading earnings history...

Guardian Pharmacy Services, Inc. (GRDN) Earnings Overview

As of November 21, 2026, Guardian Pharmacy Services, Inc. (GRDN) reported trailing twelve-month net income of $75M, reflecting +144.1% year-over-year growth. The company earned $1.17 per diluted share over the past four quarters, with a net profit margin of 3.4%.

Looking at the long-term picture, GRDN's 5-year EPS compound annual growth rate (CAGR) stands at +18.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $49M in fiscal 2025, representing a new all-time high.

Guardian Pharmacy Services, Inc. maintains positive profitability with a gross margin of 19.5%, operating margin of 6.1%, and net margin of 3.4%. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including OMCL ($45M net income, 0.2% margin), CVS ($11.05B net income, 0.4% margin), MCK ($4.70B net income, 1.2% margin), GRDN has outperformed on profitability metrics. Compare GRDN vs OMCL →

GRDN Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
GRDN logoGRDNCurrent
$75M$1.173.4%26.8%+144.1%—
OMCL logoOMCL
$45M$0.960.2%0.2%-83.6%
CVS logoCVS
$11.1B$8.560.4%2.3%-62.0%
MCK logoMCK
$4.7B$40.271.2%-+49.2%
CAH logoCAH
$1.8B$7.800.7%-+12.1%
VEEV logoVEEV
$1.0B$6.1528.4%13.9%+25.9%
Best in group
Lowest in group

GRDN Historical Earnings Data (2018–2025)

8 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$49M+156.4%$89M$0.783.4%6.1%
2024-$87M-465.2%-$63M$-1.77-7.1%-5.1%
2023$24M-32.5%$41M$0.392.3%3.9%
2022$35M+117.1%$52M$0.583.9%5.7%
2021$16M-18.2%$30M$0.272.1%3.8%
2020$20M-8.3%$32M$0.332.7%4.4%
2019$22M+48.1%$34M$0.363.1%4.9%
2018$15M-$26M$0.242.4%4.3%

Download Data

Export GRDN earnings history in CSV or JSON format

Free sign-in required to download data

Consensus & Technical Research Suite
Open GRDN Terminal

GRDN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

8+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GRDN — Frequently Asked Questions

Quick answers to the most common questions about buying GRDN stock.

What is GRDN earnings per share (EPS)?

GRDN trailing twelve-month (TTM) diluted EPS is $1.17, reflecting +144.1% year-over-year growth. The 5-year EPS CAGR is +18.8%. Complete EPS history from 2018 to 2025 is available in the table on this page.

What is Guardian Pharmacy Services, Inc.'s net income?

Guardian Pharmacy Services, Inc. (GRDN) trailing twelve-month net income is $75M as of 2025. Earnings grew +144.1% year-over-year.

Is GRDN profitable?

Yes, GRDN is profitable with a TTM net income of $75M and a net profit margin of +3.4%.

What is GRDN's earnings growth rate?

GRDN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: +10.4%, 5-Year: +18.8%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.

What are GRDN's profit margins?

Guardian Pharmacy Services, Inc. net profit margin is +3.4%, operating margin is +6.1%, and gross margin is +19.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is +26.8%.

Is GRDN growing earnings?

Yes, GRDN earnings are accelerating — EPS growth of +144.1% exceeds the 5-year CAGR of +18.8%. TTM net income reached $75M. Earnings momentum is strengthening.

What was GRDN's best earnings year?

Guardian Pharmacy Services, Inc.'s highest annual net income on record is $49M, achieved in fiscal year 2025. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.

What were GRDN's earnings last quarter?

GRDN's most recent reported quarter was Q3 2026. Net income was $19M with diluted EPS of $0.29. For a full breakdown of all quarters, see the quarterly earnings table on this page.

GRDN Earnings Over Time (2018–2025)

Net income & EPS — annual and quarterly view